Judges Scientific plc
JDG.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.38 | 0.48 | -0.66 | -0.02 |
| FCF Yield | 1.40% | 3.56% | 0.24% | 2.12% |
| EV / EBITDA | 43.91 | 36.29 | 58.03 | 25.98 |
| Quality | ||||
| ROIC | 3.80% | 5.14% | 3.35% | 10.99% |
| Gross Margin | 19.09% | 13.60% | 12.17% | 77.54% |
| Cash Conversion Ratio | 2.25 | 3.55 | 1.10 | 1.76 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.04% | 18.43% | 17.92% | 15.84% |
| Free Cash Flow Growth | -58.00% | 1,150.00% | -88.24% | 115.87% |
| Safety | ||||
| Net Debt / EBITDA | 3.41 | 3.28 | 4.36 | 1.93 |
| Interest Coverage | 4.20 | 4.50 | 3.79 | 10.42 |
| Efficiency | ||||
| Inventory Turnover | 1.90 | 2.24 | 1.91 | 0.63 |
| Cash Conversion Cycle | 42.89 | 62.40 | 52.34 | 130.59 |